These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28516751)

  • 1. Growth Hormone Therapy and Brain Tumors.
    Teramoto A
    Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):229-234. PubMed ID: 28516751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy.
    Gasco V; Caputo M; Cambria V; Beccuti G; Caprino MP; Ghigo E; Maccario M; Grottoli S
    Endocrine; 2019 Feb; 63(2):341-347. PubMed ID: 30341707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial endodermal sinus tumors associated with growth hormone replacement therapy in a girl.
    Tang Z; Shi X; Singh Khatri Chhetri KI; Qi X
    J Neurosurg Pediatr; 2012 Jan; 9(1):49-53. PubMed ID: 22208321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
    Losa M; Gatti E; Rossini A; Lanzi R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
    Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
    Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
    Smith TR; Cote DJ; Jane JA; Laws ER
    J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of sellar and suprasellar tumors in children treated with hGH--relation to immunohistochemical study on GH receptor.
    Uchino Y; Saeki N; Iwadate Y; Yasuda T; Konda S; Watanabe T; Wada K; Kazukawa I; Higuchi Y; Iuchi T; Tatsuno I; Yamaura A
    Endocr J; 2000 Mar; 47 Suppl():S33-6. PubMed ID: 10890179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
    Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of growth hormone on pituitary tumour growth.
    Herring R; Russell-Jones D
    Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.
    Buchfelder M; Kann PH; Wüster C; Tuschy U; Saller B; Brabant G; Kleindienst A; Nomikos P;
    Eur J Endocrinol; 2007 Aug; 157(2):149-56. PubMed ID: 17656592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
    Frajese G; Drake WM; Loureiro RA; Evanson J; Coyte D; Wood DF; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5172-5. PubMed ID: 11701673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-functioning pituitary macroadenomas: Benefit from early growth hormone substitution after surgery.
    Sauer N; Flitsch J; Doeing I; Dannheim V; Burkhardt T; Aberle J
    Growth Horm IGF Res; 2014; 24(2-3):71-5. PubMed ID: 24726277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
    Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
    Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
    Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review.
    Bogarin R; Steinbok P
    Childs Nerv Syst; 2009 Mar; 25(3):273-9. PubMed ID: 19142625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of growth hormone replacement after CNS irradiation.
    Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
    Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
    Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor enlargement in two patients with acromegaly during pegvisomant therapy.
    Frohman LA; Bonert V
    Pituitary; 2007; 10(3):283-9. PubMed ID: 17534717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.